Challenges in health economics and market access are universal, affecting large pharmaceutical companies and small biotech startups alike. In this article, Xtalks spoke with Dr. Heather McDonald, PhD, VP of Market Access and Pricing at AstraZeneca, to understand the challenges of HEOR and market access for innovative therapies and the effects of value-based healthcare on pricing decisions.
TORONTO, Oct. 4, 2023 /PRNewswire-PRWeb/ — Health economics and outcomes research (HEOR) and market access strategies are critical in ensuring that newly approved therapies are made available to patients.
In an article published today, Xtalks spoke with Dr. Heather McDonald, PhD, VP of Market Access and Pricing at AstraZeneca to understand the challenges of HEOR and market access for innovative therapies and the effects of value-based healthcare on pricing decisions. With over 20 years of experience in market access and pricing in the pharmaceutical industry, Dr. McDonald has worked in country-level and global roles, working on all components of core market access areas: health economics, access strategy, pricing, government affairs and patient advocacy.
In this interview, Dr. McDonald discussed the process of strategic decision-making around products that are in the early stage of development and are still years from regulatory approval and launch.
Dr. McDonald spoke about how the shift toward value-based healthcare is affecting drug pricing and reimbursement. She also shared what market access and pricing can look like for small biotechs.
Dr. McDonald is the chairperson for the upcoming HEOR Peer Circle, an exclusive think-tank of high-level industry professionals looking for collaborative solutions to common challenges. Click here to learn more about how you can access this members-only event.
To read the full interview article featuring Dr. Heather McDonald, visit: HEOR and Market Access Strategies in Today’s Drug Development Landscape – Insights from AstraZeneca’s Dr. Heather McDonald.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]